Intradialytic acid-base changes and organic anion production during high versus low bicarbonate hemodialysis

Am J Physiol Renal Physiol. 2020 Jun 1;318(6):F1418-F1429. doi: 10.1152/ajprenal.00036.2020. Epub 2020 Apr 20.

Abstract

The use of high dialysate bicarbonate for hemodialysis in end-stage renal disease is associated with increased mortality, but potential physiological mediators are poorly understood. Alkalinization due to high dialysate bicarbonate may stimulate organic acid generation, which could lead to poor outcomes. Using measurements of β-hydroxybutyrate (BHB) and lactate, we quantified organic anion (OA) balance in two single-arm studies comparing high and low bicarbonate prescriptions. In study 1 (n = 10), patients became alkalemic using 37 meq/L dialysate bicarbonate; in contrast, with the use of 27 meq/L dialysate, net bicarbonate loss occurred and blood bicarbonate decreased. Total OA losses were not higher with 37 meq/L dialysate bicarbonate (50.9 vs. 49.1 meq using 27 meq/L, P = 0.66); serum BHB increased in both treatments similarly (P = 0.27); and blood lactate was only slightly higher with the use of 37 meq/L dialysate (P = 0.048), differing by 0.2 meq/L at the end of hemodialysis. In study 2 (n = 7), patients achieved steady state on two bicarbonate prescriptions: they were significantly more acidemic when dialyzed against a 30 meq/L bicarbonate dialysate compared with 35 meq/L and, as in study 1, became alkalemic when dialyzed against the higher bicarbonate dialysate. OA losses were similar to those in study 1 and again did not differ between treatments (38.9 vs. 43.5 meq, P = 0.42). Finally, free fatty acid levels increased throughout hemodialysis and correlated with the change in serum BHB (r = 0.81, P < 0.001), implicating upregulation of lipolysis as the mechanism for increased ketone production. In conclusion, lowering dialysate bicarbonate does not meaningfully reduce organic acid generation during hemodialysis or modify organic anion losses into dialysate.

Keywords: bicarbonate; hemodialysis; ketones; lipolysis; organic anion.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Hydroxybutyric Acid / blood*
  • Acid-Base Equilibrium*
  • Adult
  • Aged
  • Aged, 80 and over
  • Alkalosis / blood*
  • Alkalosis / diagnosis
  • Alkalosis / etiology
  • Alkalosis / physiopathology
  • Bicarbonates / administration & dosage*
  • Bicarbonates / adverse effects
  • Bicarbonates / metabolism
  • Biomarkers / blood
  • Fatty Acids, Nonesterified / blood
  • Female
  • Hemodialysis Solutions / administration & dosage*
  • Hemodialysis Solutions / adverse effects
  • Hemodialysis Solutions / metabolism
  • Humans
  • Hydrogen-Ion Concentration
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / diagnosis
  • Kidney Failure, Chronic / physiopathology
  • Kidney Failure, Chronic / therapy*
  • Lactic Acid / blood*
  • Lipolysis
  • Male
  • Middle Aged
  • Renal Dialysis* / adverse effects
  • Time Factors
  • Treatment Outcome

Substances

  • Bicarbonates
  • Biomarkers
  • Fatty Acids, Nonesterified
  • Hemodialysis Solutions
  • Lactic Acid
  • 3-Hydroxybutyric Acid